Innovation Names Marvin Richardson Chief Executive Officer

JOHNSON CITY, N.Y., April 7, 2020 /PRNewswire/ — Innovation, the market-leading provider of high-volume pharmacy automation technology and software solutions to the retail, hospital, federal health care, and mail order pharmacy markets, today announced that Marvin Richardson will become the company’s chief executive officer effective April 25th. Richardson replaces Mary Reno, who has served as the chief executive officer since 1998. Ms. Reno will continue to serve on the company’s board of directors as chairwoman emeritus.

Richardson has served as co-president since December 2019 when an investor consortium led by Greg Wasson, former Walgreens Boots Alliance CEO, acquired a majority stake in the company. Richardson is a 37-year veteran of pharmacy and health care, and an established entrepreneur, having co-founded Capstone Consulting LLC, a pharmacy automation consulting company, in 2015. Prior companies founded and co-owned by Richardson include Low Cost Health Care, PrairieStone Pharmacies, and DailyMed, a compliance packaging company. Richardson has also worked as a corporate leader with Rite Aid and Walgreens, where he began his pharmacy career.

“Innovation is here for our customers who provide critical pharmaceutical care,” said Marvin Richardson, CEO of Innovation. “We believe that advancing the profession of pharmacy is a critical component for improving patient care. Innovation, with its industry leading technology and software, is transforming pharmacy practice in order to free up time for pharmacists across the country to focus on our singular and collective motivation – the patient.”

Ms. Reno has spent more than thirty years in executive roles in the health care industry and worked closely with Innovation founder and former CTO Harry Boyer in 1997 to lead the firm and its automation platform developed for the retail pharmacy industry. Since its launch, Innovation has grown in both revenue and employees, and now stands as the industry leader in providing high-volume pharmacy automation systems. Ms. Reno was the recipient of Drug Store News’ Top Women Career Achievement award in November 2019 for her service to the industry.

“These changes further position Innovation with the professional management necessary to capitalize on the explosive growth opportunities before us. I’m grateful to have had the opportunity to lead Innovation, pleased to hand over the reins to Marv, and expect Innovation to flourish under his leadership while remaining true to the values our family established when we began Innovation,” said Ms. Reno.

Innovation also announced that Co-President Tom Boyer would assume the role of Chief Strategy Officer for the company. Boyer will lead Innovation’s strategy initiatives by formulating and communicating company goals, and developing the plans and coordination with Innovation customers and industry partners to advance the company’s position of industry leadership.

About Innovation
Innovation is the leading provider of Pharmacy Intelligence™ and high-volume pharmacy automation to the retail, hospital, government, and mail order pharmacy markets. Our PharmASSIST® family of pharmacy automation and Symphony® software process optimization solutions enable all types of pharmacies to increase operational efficiency, enhance patient safety, and provide a higher quality of patient care. For more information, visit www.innovat.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/innovation-names-marvin-richardson-chief-executive-officer-301036002.html

SOURCE Innovation

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

7 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

10 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

10 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

10 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

10 hours ago